The Role of 18F-FDG & 68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastatic

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to investigate the value of 18F-FDG\&68Ga-FAPI PET/CT in evaluating the outcome of conversion therapy and the prognosis of people with peritoneal metastases from gastric cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Histologically confirmed gastric adenocarcinoma with no history of resection of primary or metastatic lesions

• Peritoneal metastases of gastric cancer requiring laparoscopy for definitive diagnosis without gastric outflow tract obstruction and intestinal obstruction

• Patients voluntarily enrolled in this study by signing an informed consent form

• Age ≥ 18 years

• Eastern Cooperative Oncology Group (ECOG) score ≤ 2,

• Expected life expectancy ≥ 3 months

• Adequate organ and bone marrow function

• Willingness to adhere to the study protocol and follow-up programme

Locations
Other Locations
China
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Jiajia Hu
jiajiahu@shsmu.edu.cn
0086-13524945287
Time Frame
Start Date: 2024-06-15
Estimated Completion Date: 2029-05-31
Participants
Target number of participants: 30
Treatments
gastric cancer patients with peritoneal metastasis
Initial diagnosis of gastric cancer with peritoneal metastases, excluding other distant metastases
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital

This content was sourced from clinicaltrials.gov